To date Parkinson’s disease (PD) is diagnosed clinically and rather late in the course of the disease. There is an urgent need to find an objective, quantifiable biomarker for the diagnosis of this highly prevalent movement disorder. Researchers have now found initial evidence that a blood test to detect the alpha-synuclein protein is a viable, less invasive option to diagnose PD. The study appears in the Journal of Parkinson’s Disease, published by IOS Press, now part of Sage.
Mosquitoes detect infrared radiation for host seeking
While a mosquito bite is often no more than a temporary bother, in many parts of the world it can be scary. One mosquito species,
August 23, 2024